Virgin receives nearly $7 million of a total of $7.8 million in grants awarded to numerous faculty in Immunobiology and Laboratory & Genomic Medicine. Congratulations to all!
Gaya Amarasinghe, PhD, Associate Professor of Pathology & Immunology, of Biochemistry and Molecular Biophysics, and of Molecular Microbiology, received a one-year $122,000 grant from the National Institutes of Health, entitled “Characterization of IFIT Proteins and Their Role in Antiviral Immunity”.
Deepta Bhattacharya, PhD, Associate Professor of Pathology & Immunology, received a two-year $196,000 subagreement from the New York Stem Cell Foundation, entitled “Generation of Immune Privileged Stem Cell Derived Beta Cells by Genome Editing”.
Thomas Hannan, DVM, PhD, Instructor in Pathology & Immunology, received a one-year $147,588 Sponsored Research Agreement (SRA) from Ocean Spray, entitled “The Effect of Cranberry on Urine Cytokine Levels During Urinary Tract Infection”.
Gwendolyn Randolph, PhD, Professor of Pathology & Immunology, of Medicine, and Head of the Division of Immunobiology, received a one-year $300,000 grant from The Kenneth Rainin Foundation, entitled “Toward Identifying the Unique Pathology that Explains Ulcerative Colitis Distribution”.
Herbert Virgin, MD, PhD, Edward Mallinckrodt Professor and Chair, Pathology & Immunology, Professor of Molecular Microbiology, and of Medicine, received a five-year $3,815,279 grant from the National Institutes of Health/Office of the Director, entitled “Impact of the Intestinal Microbiome on HIV/SIV Vaccines”.
Dr. Virgin also received a three-year $3,000,000 grant from the Crohn’s and Colitis Foundation (CCFA), entitled “Ulcerative Colitis Genetics Initiative” and an 8-month $248,200 sub-award from the Gates Foundation — Stichting Amsterdam Institute for Global Health and Development (AIGHD), entitled “Rota-Biome: The Influence of the Viral, Fungal, and Bacterial Microbiome on Rotavirus Vaccine Immune Responses”.
Guoyan Zhao, PhD, Assistant Professor of Pathology and Immunology, received three-month $50,000 grant from the US Agency for International Development (USAID) / International AIDS Vaccine Initiative (IAVI), entitled “Characterize the Microbiome of Sivet Study Volunteers”.